Esperion’s Nexletol Reaches The Cholesterol Market Priced To Sell

 
• By Joseph Haas
  
Cholesterol plaque in artery
Nexletol's unique mechanism of action inhibits the synthesis of cholesterol in the liver
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip